Jocelyn Gal, Gérard Milano, Patrick Brest, Nathalie Ebran, Julia Gilhodes, Laurence Llorca, . . . Jean-Yves Pierga. (2020). VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study. MDPI AG.
Chicago Style (17th ed.) CitationJocelyn Gal, et al. VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome Under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study. MDPI AG, 2020.
MLA (9th ed.) CitationJocelyn Gal, et al. VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome Under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study. MDPI AG, 2020.